167 related articles for article (PubMed ID: 2431554)
1. [Immunopathology of diffuse malignant mesothelioma].
Stosiek P; Goertchen R
Zentralbl Allg Pathol; 1986; 132(2):119-28. PubMed ID: 2431554
[TBL] [Abstract][Full Text] [Related]
2. Immunopathology of malignant mesothelioma.
Sheibani K
Hum Pathol; 1994 Mar; 25(3):219-20. PubMed ID: 8150453
[No Abstract] [Full Text] [Related]
3. Keratin and epithelial membrane antigen immunoreactivity in nonneoplastic fibrous pleural lesions: implications for the diagnosis of desmoplastic mesothelioma.
Epstein JI; Budin RE
Hum Pathol; 1986 May; 17(5):514-9. PubMed ID: 2422109
[TBL] [Abstract][Full Text] [Related]
4. Mesothelial and related neoplasms in children and adolescents: a clinicopathologic and immunohistochemical analysis of eight cases.
Coffin CM; Dehner LP
Pediatr Pathol; 1992; 12(3):333-47. PubMed ID: 1384016
[TBL] [Abstract][Full Text] [Related]
5. [Mesothelioma and mesothelial hyperplasia].
Li LY; Luo WC; Zhu YJ
Zhonghua Nei Ke Za Zhi; 1990 Jun; 29(6):328-31, 381. PubMed ID: 2269029
[TBL] [Abstract][Full Text] [Related]
6. [Morphology, diagnosis and differential diagnosis of mesothelioma].
Wu RL; Peng JQ
Zhonghua Zhong Liu Za Zhi; 1988 Mar; 10(2):123-5. PubMed ID: 3208650
[TBL] [Abstract][Full Text] [Related]
7. [A comparative evaluation of immunohistochemical markers for the differential diagnosis between malignant mesothelioma, non-small cell carcinoma involving the pleura, and benign reactive mesothelial cell proliferation].
Szczepulska-Wójcik E; Langfort R; Roszkowski-Sliz K
Pneumonol Alergol Pol; 2007; 75(1):57-69. PubMed ID: 17541913
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous immunoenzyme staining of vimentin and cytokeratins with monoclonal antibodies as an aid in the differential diagnosis of malignant mesothelioma from pulmonary adenocarcinoma.
Mullink H; Henzen-Logmans SC; Alons-van Kordelaar JJ; Tadema TM; Meijer CJ
Virchows Arch B Cell Pathol Incl Mol Pathol; 1986; 52(1):55-65. PubMed ID: 2435052
[TBL] [Abstract][Full Text] [Related]
9. Verification of the histologic diagnosis of malignant mesothelioma in relation to the binding of an antimesothelial cell antibody.
Donna A; Betta PG; Jones JS
Cancer; 1989 Apr; 63(7):1331-6. PubMed ID: 2646006
[TBL] [Abstract][Full Text] [Related]
10. Calretinin and other mesothelioma markers in synovial sarcoma: analysis of antigenic similarities and differences with malignant mesothelioma.
Miettinen M; Limon J; Niezabitowski A; Lasota J
Am J Surg Pathol; 2001 May; 25(5):610-7. PubMed ID: 11342772
[TBL] [Abstract][Full Text] [Related]
11. [Immunohistochemistry of mesotheliomas. Technique and current diagnostic contribution of immunohistochemical markers. General review].
Galateau-Salle F
Arch Anat Cytol Pathol; 1993; 41(5-6):212-22. PubMed ID: 8135582
[TBL] [Abstract][Full Text] [Related]
12. Malignant biphasic peritoneal mesothelioma in a child: fine-needle aspiration cytology, histopathology, and immunohistochemical features along with review of literature.
Arora SK; Srinivasan R; Nijhawan R; Bansal D; Menon P
Diagn Cytopathol; 2012 Dec; 40(12):1112-5. PubMed ID: 21574263
[TBL] [Abstract][Full Text] [Related]
13. The intermediate filament cytoskeleton of malignant mesotheliomas and its diagnostic significance.
Blobel GA; Moll R; Franke WW; Kayser KW; Gould VE
Am J Pathol; 1985 Nov; 121(2):235-47. PubMed ID: 2414994
[TBL] [Abstract][Full Text] [Related]
14. Vimentin, carcinoembryonic antigen and keratin in the diagnosis of mesothelioma, adenocarcinoma and reactive pleural lesions.
al-Saffar N; Hasleton PS
Eur Respir J; 1990 Oct; 3(9):997-1001. PubMed ID: 1705232
[TBL] [Abstract][Full Text] [Related]
15. Immunocytochemical characterization of cell lines from human malignant mesothelioma: characterization of human mesothelioma cell lines by immunocytochemistry with a panel of monoclonal antibodies.
Zeng L; Fleury-Feith J; Monnet I; Boutin C; Bignon J; Jaurand MC
Hum Pathol; 1994 Mar; 25(3):227-34. PubMed ID: 7512071
[TBL] [Abstract][Full Text] [Related]
16. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions.
Friedman MT; Gentile P; Tarectecan A; Fuchs A
Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609
[TBL] [Abstract][Full Text] [Related]
17. A biphasic malignant mesothelioma of the peritoneum and pleura in a horse.
Ulrich R; Eydner M; Grün A; Haydn J; Baumgärtner W
Dtsch Tierarztl Wochenschr; 2009 May; 116(5):186-91. PubMed ID: 19462642
[TBL] [Abstract][Full Text] [Related]
18. Cytogenetic analysis of effusions from malignant mesothelioma. A diagnostic adjunct to cytology.
Granados R; Cibas ES; Fletcher JA
Acta Cytol; 1994; 38(5):711-7. PubMed ID: 8091903
[TBL] [Abstract][Full Text] [Related]
19. [A case of desmoplastic malignant mesothelioma with elevated serum CYFRA 21-1].
Nakamura H; Kitada O; Aragane K; Miyata S; Kodama T; Kuribayashi K; Nakagomi T; Takenaka N; Jin S; Nagasawa M; Sugita M
Nihon Kokyuki Gakkai Zasshi; 2002 Apr; 40(4):337-40. PubMed ID: 12096506
[TBL] [Abstract][Full Text] [Related]
20. Immunocytochemical differential diagnosis of diffuse malignant pleural mesotheliomas--a clinicomorphological study of 158 cases.
Vortmeyer AO; Preuss J; Padberg BC; Kastendieck H; Schröder S
Anticancer Res; 1991; 11(2):889-94. PubMed ID: 1712181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
